杰龙 GERN 深 沪
等待开盘 05-21 09:30:00 美东时间
1.26
+0.040
+3.28%
华盛通- 最 高1.28
- 今 开1.24
- 成交量 827.14万股
- 最 低 1.2341
- 昨 收 1.22
- 总市值 8.08亿
- 52周最高 2.01
- 市盈率 静 --
- 换手率 1.29%
- 52周最低 1.04
- 委 比 80.98%
- 总股本 6.42亿
- 历史最高 7.79
- 量 比 0.51
- 振 幅 3.76%
- 历史最低 0.75
- 每 手 1
- 风险率 0.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
<p>Geron Corporation granted stock options to five new employees on May 15, 2026, totaling 333,750 shares. The options have an exercise price of $1.29 per share, a ten-year term, and vest over four years. The first 12.5% vests after six months of employment, with the remaining shares vesting in equal installments over the next 42 months. The awards were approved by the Compensation Committee under Nasdaq Listing Rule 5635(c)(4) and the 2018 Induc...
05-18 20:01
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Geron Reports Q1 2026 Results: Full Earnings Call Transcript
On Wednesday, Geron (NASDAQ:GERN) discussed first-quarter financial results dur...
05-06 20:51
Geron posts corporate presentation outlining RYTELO commercial strategy, growth plans
Geron posts corporate presentation outlining RYTELO commercial strategy, growth plans Geron reaffirmed 2026 guidance for RYTELO net product revenue of $220 million-$240 million. Total operating expenses expected at $230 million-$240 million. Q1 2026 RYTELO net revenue reported at $51.8 million, up 3
05-06 20:50
Geron Q1 EPS $(0.01) Beats $(0.02) Estimate, Sales $51.771M Beat $50.582M Estimate
Geron (NASDAQ:GERN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 66.67 percent increase over losses of $(0.03) per share from the same
05-06 19:07
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights
Geron Corporation reported Q1 2026 financial results, with RYTELO® (imetelstat) net product revenue of $51.8 million, an 8% increase from Q4 2025. The company reaffirmed its 2026 financial guidance, expecting net product revenue of $220-$240 million and total operating expenses of $230-$240 million. Geron strengthened its leadership team with new appointments and ended Q1 2026 with $341 million in cash and marketable securities. The company also ...
05-06 11:00
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation granted Timothy Williams, its new Executive Vice President, Chief Legal Officer, and Corporate Secretary, an equity award of 2,500,000 stock options. The options, priced at $1.73 per share, vest over four years with 12.5% after six months and the rest in equal installments over the next 42 months. The grant was approved by Geron's Compensation Committee under Nasdaq Listing Rule 5635(c)(4) and the 2018 Inducement Award Plan.
04-14 20:05
Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures lower, with Dow futures down 150 points. Fastenal shares dip 4% after meeting earnings estimate. Other stocks also down.
04-13 20:02
Geron Announces Appointment of New Members to its Board of Directors
Geron Corporation announced the appointment of Patricia S. Andrews and Constantine Chinoporos to its Board of Directors. Both bring extensive experience in the biopharmaceutical industry, particularly in commercial-stage organizations. Their expertise will support Geron's strategic priorities and the commercial growth of RYTELO<sup>®</sup>, a treatment for lower-risk myelodysplastic syndromes/neoplasms (LR-MDS). Andrews and Chinoporos have held s...
03-26 12:00
新浪财经ESG：杰龙 MSCI（明晟）ESG评级调降至BB
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
03-24 10:21
